Pharma industry in Spain, or near!

That’s it, we are glad to announce that our group has taken on a project to develop and market a monoclonal antibody.

Former idea was elaborated by Cruz so big thanks to her.

We will focus in the area of inflammation, specifically on rheumatoid arthritis. We sincerely hope that this will come out well, so stay tuned for more info on the project!